| |
| |
|
| Insider
Information: |
Nodelman Oleg |
| Relationship: |
Director, 10% Owner |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
50,000 |
|
|
Indirect Shares
|
18,524,214 |
|
|
| Direct
Value |
$462,500 |
|
|
|
Indirect Value
|
$381,905,772 |
|
|
| Total
Shares |
18,574,214 |
|
|
| Total
Value |
$382,368,272 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
7
|
1
|
|
Stock
price went up :
|
7
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
7.0
|
1.0
|
| Percentage
Gain/Loss : |
 33.4%
|
11.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genvec Inc |
GNVC |
10% Owner |
|
0 |
2014-05-27 |
962,055 |
Premium* |
|
|
Kindred Biosciences, Inc. |
KIN |
Director |
2014-09-29 |
50,000 |
2014-09-29 |
614,495 |
Premium* |
|
|
Prothena Corp Plc |
PRTA |
Director, 10% Owner |
|
0 |
2019-12-03 |
9,426,640 |
Premium* |
|
|
Anaptysbio Inc |
ANAB |
Director, 10% Owner |
|
0 |
2022-05-05 |
7,521,024 |
Premium* |
|
|
Panacea Acquisition Corp. Ii |
PANA |
Director, 10% Owner |
2023-04-28 |
0 |
2023-04-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
26 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
26 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
